Nuromol Pain Relief Tablets, Paracetamol and Ibuprofen, Pack Of 16, From The Makers Of Nurofen

Product Information

Aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinease increased, blood creatinine increased, haemoglobin decreased and platelet count increased. The onset of labour may be delayed, and duration increased with an increased bleeding tendency in both mother and child (see section 4. This product is especially suitable for pain which has not been relieved by ibuprofen or paracetamol alone. In addition, consideration was given to the following issues: The risk that a person may confuse the product with paracetamol alone and take the standard paracetamol dose of 2 tablets four times a day.

From the 20th week of pregnancy onward, Nuromol Dual Action use may cause oligohydramnios resulting from foetal renal dysfunction. Symptoms of DRESS include skin rash, fever, swelling of lymph nodes, and an increase of eosinophils (a type of white blood cell). The MHRA regulates medicines and medical devices in the UK, on behalf of the UK Licensing Authority. Do not take more than six tablets of Nuromol Dual Action Pain Relief (3000 mg Paracetamol, 1200 mg Ibuprofen) in any 24 hour period.

The global evaluation of the study medication by the subjects showed high levels of satisfaction with 88. g, pruritus, urticaria, angioedema and, more rarely, exfoliative and bullous dermatoses (including epidermal necrolysis, and erythema multiforme). Based on 2 tablet dose of Nuromol compared to standard paracetamol 1000mg or standard ibuprofen 400mg alone.

The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4. NSAIDS should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn's disease) as these conditions may be exacerbated (see section 4. Peptic ulcer, gastrointestinal perforation or gastrointestinal haemorrhage, melaena haematemesis 6, mouth ulceration, exacerbation of ulcerative colitis and Crohn's disease 7, gastritis, pancreatitis, flatulence and constipation.b) The sub-licensee is not permitted the use of this software as part of a system that constitutes a SNOMED CT “Data Creation System” or “Data Analysis System”, as defined in the IHTSDO Affiliate License.